Molina Healthcare financials
$189.38−0.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.75B | $10.68B | $11.44B | $11.46B | $11.30B | $11.02B | $10.56B | $10.32B | $9.74B | $9.80B | $8.85B | $8.44B |
| Gross profit | $1.31B | $1.41B | $1.31B | $1.41B | $1.47B | $1.54B | $1.56B | $1.68B | $1.38B | $1.39B | $1.40B | $1.13B |
| Gross margin | 12.2% | 13.2% | 11.4% | 12.3% | 13.0% | 14.0% | 14.8% | 16.3% | 14.1% | 14.2% | 15.8% | 13.4% |
| Operating income | $20.0M | -$37.0M | -$161.0M | $131.0M | $245.0M | $302.0M | $363.0M | $446.0M | $298.0M | $296.0M | $122.0M | $247.0M |
| Net income | $60.0M | $14.0M | -$160.0M | $79.0M | $255.0M | $298.0M | $251.0M | $326.0M | $301.0M | $301.0M | $216.0M | $245.0M |
| Net margin | 0.6% | 0.1% | −1.4% | 0.7% | 2.3% | 2.7% | 2.4% | 3.2% | 3.1% | 3.1% | 2.4% | 2.9% |
| Diluted EPS | $1.19 | $0.27 | $-3.16 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.70 | $4.21 |
| EBITDA | $60.0M | $95.0M | -$117.0M | $176.0M | $303.0M | $350.0M | $411.0M | $493.0M | $344.0M | $341.0M | $122.0M | $289.0M |
| Operating cash flow | -$294.0M | $1.08B | -$298.0M | -$125.0M | -$302.0M | $190.0M | -$224.0M | $873.0M | -$219.0M | $214.0M | -$690.0M | $949.0M |
| Free cash flow | -$324.0M | $1.05B | -$299.0M | -$163.0M | -$344.0M | $168.0M | -$235.0M | $838.0M | -$246.0M | $187.0M | -$695.0M | $923.0M |
| Diluted shares | 51.3M | 51.0M | 50.6M | 52.5M | 53.7M | 54.8M | 56.6M | 57.7M | 58.2M | 58.3M | 58.4M | 58.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B |
| Short-term investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B |
| Total debt | $3.95B | $3.95B | $3.95B | $3.85B | $3.56B | $3.77B |
| Total assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B |
| Total liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B |
| Shareholders' equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology